Drugs, Antidepressant | featured news

GlaxoSmithKline to pay $3B for health fraud

British drugmaker GlaxoSmithKline will pay $3 billion in fines - the largest health care fraud settlement in U.S. history - for criminal and civil violations involving 10 drugs that are taken by millions of people. The Justice Department said Monday that GlaxoSmithKline PLC will plead guilty to promoting popular antidepressants Paxil and Wellbutrin for unapproved uses. The company also will plead guilty to failing to report to the government for seven years some safety problems with diabetes drug Avandia, which was restricted in the U.S. and banned in Europe after it was found in 2007 to sharply increase the risks of heart attacks and congestive heart failure.

 

Study: Americans' use of antidepressants on the rise

Study: Americans' use of antidepressants on the rise

Americans are popping more antidepressants than ever before, and non-psychiatrists are increasingly willing to prescribe the drugs to patients ...

 

GlaxoSmithKline to pay $750 million in pill case

GlaxoSmithKline to pay $750 million in pill case

Federal prosecutors in Massachusetts say pharmaceutical company GlaxoSmithKline will pay $750 million to settle allegations that it knowingly manufactured and sold adulterated drugs at its plant in Puerto Rico, including the popular antidepressant Paxil.

 

Antidepressant improves recovery from spine injury

A common antidepressant combined with an intensive treadmill training program helped people with partial spinal cord injuries walk better and faster, U.S. researchers said on Sunday.

 

Subscribe to this RSS topic: Syndicate content